Search research articles
Contact Us
Filters
Showing results (291-300 of 324) with videos related to
Page
of 33
Sort By:
FEBS Letters
|
August 2, 2012
A687V EZH2 is a gain-of-function mutation found in lymphoma patients
Christina R Majer, Lei Jin, Margaret Porter Scott, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 5, 2014
DOT1L inhibitor EPZ-5676 displays synergistic antiproliferative activity in combination with standard of care drugs and hypomethylating agents in MLL-rearranged leukemia cells
Christine R Klaus, Dorothy Iwanowicz, Danielle Johnston, et al.
The Journal of Pediatrics
|
June 19, 2012
Thiamine deficiency in Cambodian infants with and without beriberi
Debra Coats, Kelsey Shelton-Dodge, Kevanna Ou, et al.
ACS Chemical Biology
|
August 26, 2014
Reaction coupling between wild-type and disease-associated mutant EZH2
Brooke M Swalm, Sarah K Knutson, Natalie M Warholic, et al.
Journal of Biomolecular Screening
|
March 11, 2015
A High-Throughput Mass Spectrometry Assay Coupled with Redox Activity Testing Reduces Artifacts and False Positives in Lysine Demethylase Screening
Tim J Wigle, Kerren K Swinger, John E Campbell, et al.
Oncotarget
|
August 25, 2015
Suppression of β-catenin/TCF transcriptional activity and colon tumor cell growth by dual inhibition of PDE5 and 10
Nan Li, Xi Chen, Bing Zhu, et al.
The Journal of Allergy and Clinical Immunology
|
March 1, 1977
Cromolyn sodium nasal solution in the prophylactic treatment of pollen-induced seasonal allergic rhinitis
N I Handelman, G A Friday, H J Schwartz, et al.
Molecular Cancer Therapeutics
|
June 28, 2013
Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling
Nan Li, Yaguang Xi, Heather N Tinsley, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 27, 2013
Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
Sarah K Knutson, Natalie M Warholic, Tim J Wigle, et al.
Journal of Medicinal Chemistry
|
January 16, 2016
The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of Tazemetostat
Kevin W Kuntz, John E Campbell, Heike Keilhack, et al.
Page
of 33
Search research articles
Search
Showing results (291-300 of 324) with videos related to
Sort By:
Page
of 33
FEBS Letters
|
August 2, 2012
A687V EZH2 is a gain-of-function mutation found in lymphoma patients
Christina R Majer, Lei Jin, Margaret Porter Scott, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 5, 2014
DOT1L inhibitor EPZ-5676 displays synergistic antiproliferative activity in combination with standard of care drugs and hypomethylating agents in MLL-rearranged leukemia cells
Christine R Klaus, Dorothy Iwanowicz, Danielle Johnston, et al.
The Journal of Pediatrics
|
June 19, 2012
Thiamine deficiency in Cambodian infants with and without beriberi
Debra Coats, Kelsey Shelton-Dodge, Kevanna Ou, et al.
ACS Chemical Biology
|
August 26, 2014
Reaction coupling between wild-type and disease-associated mutant EZH2
Brooke M Swalm, Sarah K Knutson, Natalie M Warholic, et al.
Journal of Biomolecular Screening
|
March 11, 2015
A High-Throughput Mass Spectrometry Assay Coupled with Redox Activity Testing Reduces Artifacts and False Positives in Lysine Demethylase Screening
Tim J Wigle, Kerren K Swinger, John E Campbell, et al.
Oncotarget
|
August 25, 2015
Suppression of β-catenin/TCF transcriptional activity and colon tumor cell growth by dual inhibition of PDE5 and 10
Nan Li, Xi Chen, Bing Zhu, et al.
The Journal of Allergy and Clinical Immunology
|
March 1, 1977
Cromolyn sodium nasal solution in the prophylactic treatment of pollen-induced seasonal allergic rhinitis
N I Handelman, G A Friday, H J Schwartz, et al.
Molecular Cancer Therapeutics
|
June 28, 2013
Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling
Nan Li, Yaguang Xi, Heather N Tinsley, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
April 27, 2013
Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2
Sarah K Knutson, Natalie M Warholic, Tim J Wigle, et al.
Journal of Medicinal Chemistry
|
January 16, 2016
The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of Tazemetostat
Kevin W Kuntz, John E Campbell, Heike Keilhack, et al.
Page
of 33